2023 |
Cns Pharmaceuticals Inc
|
- |
401.5 K |
-16.6 % |
2022 |
Cns Pharmaceuticals Inc
|
Chief Financial Officer and Principal Accounting Officer |
481.2 K |
0.2 % |
2021 |
Cns Pharmaceuticals Inc
|
- |
480.5 K |
-39.3 % |
2021 |
Cns Pharmaceuticals Inc
|
Chief Financial Officer and Principal Accounting Officer |
480.5 K |
-39.3 % |
2020 |
Cns Pharmaceuticals Inc
|
- |
791.0 K |
-31.5 % |
2020 |
Cns Pharmaceuticals Inc
|
- |
791.0 K |
-31.5 % |
2020 |
Cns Pharmaceuticals Inc
|
Chief Financial Officer and Principal Accounting Officer |
791.0 K |
-31.5 % |
2019 |
Cns Pharmaceuticals Inc
|
- |
1.2 M |
- |
2019 |
Cns Pharmaceuticals Inc
|
- |
1.2 M |
- |
2019 |
Cns Pharmaceuticals Inc
|
Chief Financial Officer and Principal Accounting Officer |
1.2 M |
- |